Display Settings:

Format

Send to:

Choose Destination
    Rom J Intern Med. 2004;42(1):3-13.

    Up to date in pharmacological treatment of dilated cardiomyopathy.

    Source

    Institute of Cardiovascular Disease Prof Dr C.C. Iliescu, Bucharest, Romania.

    Abstract

    Dilated cardiomyopathy is a syndrome characterized by dilatation and impaired function of one or both ventricles and represents the most common heart failure entity requiring heart transplantation. The treatment we currently use does not directly influence specific underlying pathomechanisms of this disorder, and several attempts are being made in order to introduce more specific therapies. We summarized the most important pharmacological strategies that are being evaluated for the treatment of dilated cardiomyopathy and pointed out the novel therapeutic approaches concerning heart failure secondary to this clinical condition.

    PMID:
    15529591
    [PubMed - indexed for MEDLINE]

      Supplemental Content

      Save items

      loading

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk